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1. Introduction 
When photon-counting spectrophotofluorimetry 
was first applied to studies on the in vitro metabolic 
activation of the carcinogenic polycyclic hydrocarbons 
[l-3] , the initial studies showed that the K-region 
epoxide of 7-methylbenz [a] anthracene did not appear 
to be the species that reacted with nucleic acid in 
cells treated with the parent hydrocarbon [l] . This 
technique was later used to confirm that the meta- 
bolic activation of benzo [a] pyrene involved a vicinal 
diol-epoxide formed on the adjacent 7,8- and 9,10- 
double bonds [3]. We now wish to report the results 
of further fluorescence spectral studies on the meta- 
bolic activation of 7-methylbenz [a] anthracene (see 
formula). These show that the hydrocarbon moieties, 
+ The authors would like to dedicate this paper to the 
memory of Mme Pascaline Daudel who died in Paris on 
May 12th 1976 
* To whom correspondence should be addressed 
that become bound to DNA in hamster embryo cells 
and in mouse skin treated with this hydrocarbon, 
have spectral characteristics that are similar to those 
of DNA that has been reacted in solution with 3,4- 
dihydro-3,4-dihydroxy-7-methylbenz[a]anthracene 
1,2-oxide, but that are different from those of DNA 
that has been treated with 8,9-dihydro-8,9-dihydroxy- 
7-methylbenz[a]anthracene 10,l l-oxide. 
These and other results are consistent with our 
general hypothesis that vicinal diol-epoxides [4] are 
important in the metabolic activation of the poly 
cyclic hydrocarbons [5,6] and indicate that, with 
7-methylbenz[a]anthracene, the active metabolite is 
most probably 3,4-dihydro-3,Cdihydroxy-7-methyl-‘ 
benz [alanthracene 1,2-oxide. 
2. Materials and methods 
2.1. Materials 
7_Methylbenz[a]anthracene and 3,4-dihydro-3,4- 
dihydroxy-7-methylbenz[a]anthracene were prepared 
[7,8] and 8,9-dihydro-8,9-dihydroxy-7-methylbenz- 
[alanthracene was obtained from the hydrocarbon by 
metabolism [9]. The corresponding diol-epoxides, 
3,4-dihydro-3,4-dihydroxy-7-methylbenz[a]anthracene 
1,2-oxide and 8,9-dihydro-8,9-dihydroxy-7-methylbenz- 
[alanthracene 10,ll -oxide, were prepared from the 
North-Holland mblishing Company - Amsterdam 9 
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diols by oxidation with m-chloroperoxybenzoic acid or tissues that had been treated with 7-methylbenz- 
in tetrahydrofuran. DNA (salmon sperm, type 111, [a] anthracene, the data presented (figs 1 and 2) were 
Sigma Chemical Co., St Louis, MO, USA) was recorded on a more recent model of the instrument 
deproteinized before use by a detergent salt-procedure that is somewhat more sensitive. Emission spectra 
[lo] . 1-Methylphenanthrene and 9-methylanthracene were recorded using excitation and emission wave- 
were purchased (Aldrich Chemical Co. Gillingham, length band widths of 6 nm and of 3 nm respectively; 
Dorset, England) and purified by chromatography they have not been corrected for the response of the 
on alumina and crystallization. emission path of the instrument. 
2.2. Reactions with DNA 
DNA (20 mg) dissolved in Tris-HCl buffer (0.01 M, 
pH 7.0,20 ml) was mixed with acetone (10 ml) or 
with a solution of a diol-epoxide (1 PM) in acetone 
(10 ml) and incubated at 37°C for 24 h. DNA solutions 
were then extracted and the DNA purified and 
reisolated as described [3] except that two additional 
chloroform/isoamyl alcohol extractions were performed. 
3. Results and discussion 
DNA was also obtained from mouse skin and from 
cultures of hamster embryo cells that had been treated 
with 7-methylbenz[a]anthracene. Mouse skin DNA 
was isolated 24 h after the shaved dorsal areas of the 
skin of d C57Bl mice had been treated either with 
acetone (0.15 ml) or with a solution of 7-methylbenz- 
[alanthracene (1 PM) in acetone (0.15 ml) [3]. 
Hamster embryo cell DNA was isolated from cultures 
[5] 24 h after acetone (0.1%) or an equal volume of 
an acetone solution of 7-methylbenz [a] anthracene 
(final concentration 1 pg/ml medium) had been added 
to the media. Hamster embryo cell and mouse skin 
DNA samples were deproteinized twice [lo] and the 
aqueous solutions were then treated briefly with 
RNAase and extracted repeatedly with chloroform/ 
isoamyl alcohol [3]. 
Fluorescence emission spectra recorded using the 
photon-counting spectrophotofluorimeter are shown 
in fig. 1. From data of this type, difference spectra 
like those shown in fig.2 have been prepared. This 
illustration shows that the fluorescence spectrum 
obtained from DNA treated with the 3,4-diol 
1,2-oxide derived from 7-methylbenz [a] anthracene 
(fig.2a, spectrum 1) is quite different from that 
shown by DNA that had been incubated with the 
All purified DNA preparations intended for fluor- 
escence studies were dissolved in a Tris-NaCl buffer 
(0.1 M, pH 7.5) prepared from water distilled from 
KMn04 and then from Ba(OH)a and stored in a silica 
container. Any particles of suspended matter, which 
have been found to interfere with low level fluores- 
cence measurements, were removed from DNA solu- 
tions by centrifugation immediately prior to fluori- 
metry. 
2.3. Fluorescence spectra 
These were determined using a photon-counting 
spectrophotofluorometer of the type described [ 111. 
However, because of the extremely low levels of 
fluorescence associated with DNA obtained from cells 
Fig.1. Fluorescence spectra shown by DNA isolated from (a) 
hamster embryo cells or (b) mouse skin following treatment 
with 7-methylbenz[a]anthracene (o l l 0) or acetone (* . . .). 
DNA solutions had optical densities of (a) 1.5 and (b) 15.7 
at 260 nm and spectra were recorded as described in the text 
using the photon-counting spectrophotofluorimeter with 
excitation wavelengths of (a) 260 nm and (b) 300 nm. 
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Fig.2. Fluorescence spectra shown by DNA (a) treated with 
3,4-dihydro-3,4-dihydroxy-7-methylbenz[a]anthracene 
1,Zoxide (curve 1) or with 8,9_dihydro-8,9-dihydroxy-7- 
methylbenz[a]anthracene lO,ll-oxide (curve 2) or isolated 
from (b) hamster embryo cells or (c) mouse skin following 
treatment with ‘I-methylbenz[a]anthracene. The spectra are 
difference spectra normalized on their maxima obtained from 
samples of DNA prepared as described in the text. 
related 8,9-diol lo,1 l-oxide (fig.2a, spectrum 2). The 
spectrum obtained from the 3,4-diol 1,2-oxide treated 
DNA closely resembles that of 9-methylanthracene, 
with a shift of 7.5 nm towards longer wavelengths 
(table 1) and that shown by the 8,9-diol 10,l l-oxide 
treated DNA resembles, again with a similar shift, 
that of 1 -methylphenanthrene (table 1). The difference 
spectra obtained from 7-methylbenz[a]anthracene- 
treated and control hamster embryo cell and mouse 
skin DNA samples are shown in tig.2b and 2c 
respectively. 
The fluorescence was in both cases much less 
intense than that previously obtained in similar 
experiments with benzo [alpyrene [3] but the spectra 
are similar to the anthracene type of spectrum shown 
by DNA treated with the 3,4-diol 1,2-oxide (fig.2a,l) 
and are obviously quite different from the phenan- 
threne-type spectrum displayed by DNA following 
reaction with the related 8,9-diol 10,l l-oxide (fig.2a, 
2). The fluorescence spectrum of the DNA treated 
with the 8,9-diol lo,1 l-oxide occupies the same 
wavelengths a  that of DNA treated with the K-region 
epoxide, 7-methylbenz[a]anthracene 5,doxide. The 
emission spectrum of DNA treated with the 3,4-diol 
1,2-oxide (fig.2) show a considerable oss of structure 
in comparison with that of 9_methylanthracene, 
probably due to interaction between the hydrocarbon 
moieties and the macromolecule, and in addition there 
is an impcrtant red-shift of 7.5 nm which takes the 
spectrum to higher wavelengths than that of 7-methyl- 
benz,[a]anthracene itself (table 1). 
Previous fluorescence and other studies [1,121 
Table 1 
Fluorescence maxima (nm)a 
7-Methylbenz [a] anthracene 
9-Methylanthracene 
DNA treated with 3,4-dihydro- 
3,4-dihydroxy-7-methylbenz [ a] - 
anthracene 1,Zoxide 
1-Methylphenanthrene 
DNA treated with 8,9-dihydro- 
8,9-dihydroxy-7-methylbenz- 
[alanthracene 10,l l-oxide 
398 420 444 471.5 
397 417.5 442 470 495 
407 425 455 
(shoulder) (shoulder) 
356.6 373 392.5 412.5 440 
362.5 380 400 420 
a The spectra of the hydrocarbons were measured in ethanol and those of the DNA samples in 
buffer as described in the text. 
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have helped to exclude the K-region epoxide and 
carbonium ions formed on the methyl group from 
those active species that may be formed when 
7-methylbenz[a]anthracene is metabolized in vivo. 
The results presented here appear to exclude a vicinal 
diol-epoxide formed on the 8,9- and 10,l l-double 
bonds from this activation process but are not 
inconsistent with the formation of a biologically 
important vicinal diol-epoxide in the 1,2,3,4-positions; 
further studies are, however, required to prove this 
conclusively. Although the 1,2-diol has not been 
described as a metabolite of 7-methylbenz [a] anthra- 
cene, the 3,4-diol has been detected [ 131. When tested 
in bacterial and mammalian cell mutagenicity test 
systems and in an in vitro malignant transformation 
system, which are all systems where further meta- 
bolism can occur, the 3,4-diol derived from 7-methyl- 
benz [a] anthracene has been found to be more active 
than either the parent hydrocarbon or other dihydro- 
diols [14,15]. In addition, in experiments that are 
still in progress, this diol is proving to be a potent 
mouse skin tumour initiating agent [ 161 . In total 
therefore the information now available strongly 
suggests that the metabolic activation of 7-methyl- 
benz [a] anthracene involves the formation of the 
vicinal diol-epoxide 3,4-dihydro-3,4-dihydroxy-7- 
methylbenz [a ] anthracene 1,2-oxide. 
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